Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 3Withdrawn 2Unknown 2

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 5Breast 3Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 3

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Ibandronic Acid × Breast × Clear all
NCT00127205 2021-07-02

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

SWOG Cancer Research Network

Phase 3 Completed
6,097 enrolled 20 charts
Breast

Breast Neoplasms

NCT02616744 2019-10-22

BONADIUV

Azienda Ospedaliero-Universitaria Careggi

Phase 2 Completed
171 enrolled
Breast

Breast Neoplasms

NCT00196859 2014-07-17

Study in Elderly Patients With Early Breast Cancer (ICE)

GBG Forschungs GmbH

Phase 3 Completed
1,500 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡